An Adult And Adolescent Schizophrenia Study To Evaluate The Effects Of Extended Release Injectable
Posted Date: Jan 28, 2020
- Investigator: Caleb Adler
- Specialties: Adolescent Psychiatry/Psychology, Psychiatry/Psychology
- Type of Study: Drug
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Risperidone Extended-Release Injectable Suspension (TV-46000) for Subcutaneous Use as Maintenance Treatment in Adult and Adolescent Patients with Schizophrenia (The RISE Study – The RIsperidone Subcutaneous Extended-release Study)
Criteria:
13 Through 65 Years, Diagnosis Of Schizophrenia
Keywords:
Adult, Adolescent, Schizophrenia
For More Information:
Karen Tugrul, Bsn, Rn
513.558.6831
karen.tugrul@uc.edu